Edinburgh Research Explorer Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors
Edinburgh Research Explorer Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors
复制标题
DOI:
--
复制
发表时间:
--
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
High rates of APOBEC-signature mutations are found in many tumors, but factors affecting this 47 mutation pattern are not well understood. Here, we explored the contribution of two common 48 germline variants in the APOBEC3 region. A single nucleotide polymorphism, rs1014971, was 49 associated with bladder cancer risk, increased APOBEC3B ( A3B ) expression, and enrichment 50 with APOBEC-signature mutations in bladder tumors. In contrast, a 30 Kb deletion that 51 eliminates A3B and creates A3AB chimera, was not important in bladder cancer, while being 52 associated with breast cancer risk and enrichment with APOBEC-signature mutations in breast 53 tumors. In vitro, A3B was predominantly induced by treatment with a DNA-damaging drug in 54 bladder cancer cell lines and A3A was induced as part of antiviral interferon-stimulated response 55 in breast cancer cell lines. These findings suggest a tissue-specific role of environmental 56 oncogenic triggers, particularly in individuals with germline APOBEC3 risk variants. 57